Isomorphic Labs raises $5bn from Sequoia and Greenoaks for AI drug design

Wait 5 sec.

Isomorphic Labs, the Alphabet drug discovery company run by Demis Hassabis, has raised $5bn in a Series C round co-led by Greenoaks and Sequoia Capital. The company announced the round on Tuesday, six months after it raised $2.1bn in May. Andreessen Horowitz and several other new investors joined, with what Isomorphic called continued significant investment […]This story continues at The Next Web